No Data
No Data
Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor
Dr. Selvaggi was instrumental in the development and approval of lung cancer drugs Zykadia for Novartis and Opdivo for Bristol Myers Squibb CEL-SCI's Multikine immunotherapy improves the 5-year survival of head and
Express News | CEL-SCI Q2 2024 GAAP EPS $(0.28) Misses $(0.14) Estimate
Express News | CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results
CEL-SCI 2Q Loss/Shr 14c >CVM
CEL-SCI 2Q Loss/Shr 14c >CVM
CEL-SCI | 10-Q: Quarterly report
CEL-SCI(CVM.US) Director Buys US$27,800 in Common Stock
$CEL-SCI(CVM.US)$ Director Watson Robert Eugene purchased 20,000 shares of common stock on May 8, 2024 at an average price of $1.39 for a total value of $27,800.Source: Announcement What is statement
No Data